...
首页> 外文期刊>Biological & pharmaceutical bulletin >Packaging of the Coenzyme Q(10) into a Liposome for Mitochondrial Delivery and the Intracellular Observation in Patient Derived Mitochondrial Disease Cells
【24h】

Packaging of the Coenzyme Q(10) into a Liposome for Mitochondrial Delivery and the Intracellular Observation in Patient Derived Mitochondrial Disease Cells

机译:将辅酶Q(10)的包装成脂质体用于线粒体递送和患者衍生线粒体疾病细胞的细胞内观察

获取原文
获取原文并翻译 | 示例

摘要

While Coenzyme Q(10) (CoQ(10)) is thought to be effective for the treatment of a variety of diseases, it limits its cellular uptake. Because of the hydrophobic nature of CoQ(10), it is reasonable to assume that it could be encapsulated within a liposomal carrier. Several reports regarding the packaging of CoQ(10) in liposomes have appeared, but detailed investigations of the preparation of CoQ(10) encapsulated liposomes have not been reported. As a result, information regarding the optimal method of packaging CoQ(10) in liposomes is not available. In this study, several types of liposomes were prepared using different methods and their characteristics were compared. Since CoQ(10) is mainly located in the inner mitochondria! membrane, a liposome that targets mitochondria, a MITO-Porter, was used as a model liposome. It was possible to incorporate high levels of CoQ(10) into the carrier. Transmission electron microscopy analyses showed that an empty MITO-Porter and the CoQ(10)-MITO-Porter were structurally different from one another. Even though significant structural differences were observed, mitochondria! delivery was not affected in mitochondria! disease fibroblast cells, as evidenced by confocal laser scanning microscopy observations. The results reported herein suggest that the CoQ(10)-MITO-Porter might be a suitable candidate for the potential medical therapy of mitochondria-related diseases.
机译:虽然辅酶Q(10)(CoQ(10))被认为是治疗各种疾病的有效性,但它限制了其细胞摄取。由于Coq(10)的疏水性质,假设它可以包封在脂质体载体中是合理的。似乎还概述了关于脂质体中CoQ(10)包装的报告,但尚未报道对CAQ(10)克Q(10)型包封脂质体的制备的详细研究。结果,不可用关于包装CAQ(10)的最佳方法的信息。在该研究中,使用不同的方法制备几种类型的脂质体,并比较它们的特性。由于CAQ(10)主要位于内部线粒体中!膜,一种靶向线粒体,Mito-porter的脂质体用作模型脂质体。可以将高水平的CAQ(10)掺入载体中。透射电子显微镜分析表明,空的MITO-波特和COQ(10)-Mito-porter彼此结构不同。尽管观察到显着的结构差异,但线粒体!发出不受线粒体的影响!疾病成纤维细胞,通过共聚合激光扫描显微镜观察证明。本文报道的结果表明,COQ(10)-Mito-porter可能是对线粒体相关疾病的潜在医疗治疗的合适候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号